Chenhong Pharmaceutical (002550.SZ) released its half-year financial results, with a net profit attributable to the parent company of 2.58 billion yuan, an increase of 41.17%.

Zhijing Finance APP News, Qianhong Pharmaceutical (002550.SZ) released its 2025 interim report. The company's operating income was 862 million yuan, a year-on-year increase of 0.72%. Net profit attributable to shareholders of the listed company was 258 million yuan, a year-on-year increase of 41.17%. Net profit attributable to shareholders of the listed company (excluding non-recurring gains and losses) was 199 million yuan, a year-on-year increase of 10.71%. Basic earnings per share was 0.2065 yuan.